By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sunesis Pharmaceuticals, Inc. 

395 Oyster Point Boulevard
Suite 400
South San Francisco  California  94080  U.S.A.
Phone: 650-266-3500 Fax: 650-266-3501


SEARCH JOBS


Industry
Pharmaceutical

Segment
Biotechnology

Collaborations

Merck & Co., Inc.  Alzheimer's disease, Antivirals

Biogen Idec, Inc. (California)  Cancer Therapeutics

Johnson & Johnson Pharmaceutical Research & Development, LLC (CA)  Inflammatory and Autoimmune Diseases





Company News
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On August 5th To Discuss Second Quarter 2014 Financial Results And Recent Highlights 7/29/2014 8:52:16 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces European Medicines Agency Acceptance Of Pediatric Investigation Plan For Qinprezo™ (Vosaroxin) For AML 7/9/2014 10:45:28 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At The 2014 Wells Fargo Healthcare Conference 6/11/2014 7:29:13 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Updated Results From Ongoing MD Anderson Cancer Center-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS At American Society of Clinical Oncology 2014 Annual Meeting 6/2/2014 10:06:35 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Present At Upcoming Investor Conferences 5/14/2014 10:43:39 AM
Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results And Recent Highlights 5/7/2014 8:57:12 AM
Sunesis Pharmaceuticals, Inc. (SNSS) To Host Conference Call On May 7th To Discuss First Quarter 2014 Financial Results And Recent Highlights 4/30/2014 9:11:28 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces MD Anderson Sponsored Study Of Vosaroxin In AML And High-Risk MDS Poster To Be Presented At American Society of Clinical Oncology 2014 4/22/2014 9:13:26 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Presentation Of Positive Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS 4/8/2014 7:37:18 AM
Sunesis Pharmaceuticals, Inc. (SNSS) Announces MD Anderson Cancer Center Sponsored Trial Of Vosaroxin In AML And High-Risk MDS Poster To Be Presented At American Association for Cancer Research 2014 4/2/2014 8:53:57 AM
12345678910...
//-->